Literature DB >> 6095437

Lactoferrin receptors in normal and leukaemic human blood cells.

H S Birgens, H Karle, N E Hansen, L Ostergaard Kristensen.   

Abstract

The binding of 125I-lactoferrin to a variety of peripheral blood cells was examined. In the concentration range from 10(-9) mol/l to 10(-6) mol/l a receptor-like binding of lactoferrin was observed in monocytes as well as in polymorphonuclear leucocytes. At the low concentrations of lactoferrin in plasma (about 10(-9) mol/l) the cellular binding to monocytes was about 10 times higher than the binding to polymorphonuclear leucocytes and lymphocytes. A major result from a kinetic analysis was a lower apparent binding affinity to polymorphonuclear leucocytes (KD about 2 X 10(-7) mol/l) than to lymphocytes and monocytes (KD about 2 X 10(-8) mol/l). Studies in leukaemic cells showed that lymphocytes from patients with chronic lymphocytic leukaemia bound lactoferrin to the same small extent as normal lymphocytes. In contrast, a larger component of binding with high affinity (KD about 2 X 10(-8) mol/l) could be demonstrated to lymphoblasts as well as to myeloblasts.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095437     DOI: 10.1111/j.1600-0609.1984.tb02228.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  2 in total

1.  The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Authors:  D Legrand; P H van Berkel; V Salmon; H A van Veen; M C Slomianny; J H Nuijens; G Spik
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

2.  M860, a Monoclonal Antibody against Human Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin via Granzyme B Induction.

Authors:  Ya Li; Jie Li; Zheng Gong; Xiao-Hua Pan; Zi-Han Ma; Shu-Yan Ma; Hong-Min Wang; Hong-Liang Dong; Fang-Yuan Gong; Xiao-Ming Gao
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.